{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk;", "lead_paragraph": "IF you are one of the millions of Americans trying to stop or reverse serious clogging of your coronary arteries, how do you know whether the changes you have made in your daily habits or the drugs you are taking to lower cholesterol are having the desired effect? A new study, being published today in The Journal of the American Medical Association, has shown that a scanning technique now used mainly to assess problems in the brain can effectively measure blood flow to the heart and show whether behavioral changes or drug therapy or both have reduced a person's chances of suffering a heart attack.", "headline": {"main": "Do Plans to Cut Heart Risk Work? In Study, PET Scans Keep Track"}, "abstract": null, "print_page": "11", "word_count": 1005, "_id": "4fd1f3c48eb7c8105d74bf14", "snippet": "IF you are one of the millions of Americans trying to stop or reverse serious clogging of your coronary arteries, how do you know whether the changes you have made in your daily habits or the drugs you are taking to lower cholesterol are having the...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1995/09/20/us/do-plans-to-cut-heart-risk-work-in-study-pet-scans-keep-track.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "creative_works", "value": "HEALTH PAGE (NYT)"}, {"name": "persons", "value": "ORNISH, DEAN"}, {"name": "organizations", "value": "POSITRON EMISSION TOMOGRAPHY"}, {"name": "subject", "value": "DIET AND NUTRITION"}, {"name": "subject", "value": "HEART"}, {"name": "subject", "value": "LIFE STYLES"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "EXERCISE"}, {"name": "subject", "value": "CHOLESTEROL"}], "byline": {"person": [{"firstname": "Jane", "middlename": "E.", "lastname": "BRODY", "rank": 1, "role": "reported", "organization": ""}], "original": "By JANE E. BRODY"}, "document_type": "article", "pub_date": "1995-09-20T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "LIKE the late Richard M. Nixon, the notorious University of Maryland conference on the genetics of criminal behavior has been deplored, defeated, kicked around, thrown to the ground, hounded offstage, and still it lurches back to the ring, fists clenched, eager to fight the fight of its own design. Three years ago, David Wasserman, a legal scholar at the University of Maryland and his colleagues caused a political Pinatubo when they sought to organize a meeting to discuss, as they put it, \"the meaning and significance of research on genetics and criminal behavior.\"", "headline": {"main": "Disputed Meeting To Ask if Crime Has Genetic Roots"}, "abstract": null, "print_page": "1", "word_count": 2271, "_id": "4fd1d0eb8eb7c8105d70adc4", "snippet": "LIKE the late Richard M. Nixon, the notorious University of Maryland conference on the genetics of criminal behavior has been deplored, defeated, kicked around, thrown to the ground, hounded offstage, and still it lurches back to the ring, fists...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1995/09/19/science/disputed-meeting-to-ask-if-crime-has-genetic-roots.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "WASSERMAN, DAVID"}, {"name": "organizations", "value": "UNIVERSITY OF MARYLAND"}, {"name": "subject", "value": "AGGRESSION"}, {"name": "subject", "value": "VIOLENCE"}, {"name": "subject", "value": "WHITE COLLAR CRIME"}, {"name": "subject", "value": "BLACKS"}, {"name": "subject", "value": "GENETICS AND HEREDITY"}, {"name": "subject", "value": "MINORITIES (ETHNIC, RACIAL, RELIGIOUS)"}, {"name": "subject", "value": "CRIME AND CRIMINALS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Natalie", "lastname": "ANGIER"}], "original": "By NATALIE ANGIER"}, "document_type": "article", "pub_date": "1995-09-19T00:00:00Z", "section_name": "Science; Health"}, {"type_of_material": "Special Report", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Fresh out of medical school and in need of money, Dr. Gail Mullen signed up with a temporary help service for professionals last year and was sent to the Houston office of Dr. Robert I. Lewy. What she found there startled her.", "headline": {"main": "Doctors, Lawyers and Silicone: A special report.; Implant Lawsuits Create A Medical Rush to Cash In"}, "abstract": null, "print_page": "1", "word_count": 3473, "_id": "4fd201f68eb7c8105d767126", "snippet": "Fresh out of medical school and in need of money, Dr. Gail Mullen signed up with a temporary help service for professionals last year and was sent to the Houston office of Dr. Robert I. Lewy.   What she found there startled her.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1995/09/18/us/doctors-lawyers-silicone-special-report-implant-lawsuits-create-medical-rush.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "HAZARDOUS AND TOXIC SUBSTANCES"}, {"name": "subject", "value": "BREAST"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "ETHICS"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "WOMEN"}, {"name": "subject", "value": "IMPLANTS"}, {"name": "subject", "value": "SILICONE"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gina", "lastname": "KOLATA"}, {"organization": "", "role": "reported", "rank": 2, "firstname": "Barry", "lastname": "MEIER"}], "original": "By GINA KOLATA and BARRY MEIER"}, "document_type": "article", "pub_date": "1995-09-18T00:00:00Z", "section_name": "Front Page; Health; U.S."}, {"type_of_material": "Editorial", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "House Speaker Newt Gingrich promised a bold, market-driven reform of Medicare. He has not delivered. The policy he outlined on Friday would shut off effective competition and possibly damage health care for the elderly. Perhaps the Senate leadership plan, to be released this week, will do better. Medicare is, as Mr. Gingrich never ceases to charge, excessively costly and out of date, having adopted few of the innovative techniques that are used in the private sector to improve quality and lower costs. Mr. Gingrich would solve these problems by, in effect, giving the elderly the option of using a Government voucher to buy private coverage. But the proposal reneges on introducing market competition when it denies health plans the right to rebate part of the voucher to enrollees. Private plans would have no incentive to cut premiums below the amount of the voucher.", "headline": {"main": "Medicare Misfire"}, "abstract": null, "print_page": "14", "word_count": 540, "_id": "4fd1f3c58eb7c8105d74bf53", "snippet": "House Speaker Newt Gingrich promised a bold, market-driven reform of Medicare. He has not delivered. The policy he outlined on Friday would shut off effective competition and possibly damage health care for the elderly. Perhaps the Senate leadership...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1995/09/17/opinion/medicare-misfire.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "GINGRICH, NEWT"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "REFORM AND REORGANIZATION"}, {"name": "subject", "value": "EDITORIALS"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": null, "document_type": "article", "pub_date": "1995-09-17T00:00:00Z", "section_name": "Health; Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "After years of recommending AZT as the first-line drug for treating the virus that causes AIDS, Federal health officials are considering a change because of surprising results with other drugs. Dr. Anthony S. Fauci, the director of the National Institute of Allergy and Infectious Diseases, said in an interview that he planned to convene a meeting where independent experts could decide whether AZT should remain the first choice.", "headline": {"main": "Experts to Review AZT Role As the Chief Drug for H.I.V."}, "abstract": null, "print_page": "38", "word_count": 954, "_id": "4fd1ec428eb7c8105d73cfbd", "snippet": "After years of recommending AZT as the first-line drug for treating the virus that causes AIDS, Federal health officials are considering a change because of surprising results with other drugs.    Dr. Anthony S. Fauci, the director of the National...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1995/09/17/us/experts-to-review-azt-role-as-the-chief-drug-for-hiv.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "FAUCI, ANTHONY S"}, {"name": "subject", "value": "DIDANOSINE (DDI) (DRUG)"}, {"name": "subject", "value": "AZT (AZIDOTHYMIDINE) (DRUG)"}, {"name": "subject", "value": "ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"}], "byline": {"person": [{"firstname": "Lawrence", "middlename": "K.", "lastname": "ALTMAN", "rank": 1, "role": "reported", "organization": ""}], "original": "By LAWRENCE K. ALTMAN"}, "document_type": "article", "pub_date": "1995-09-17T00:00:00Z", "section_name": "Health; U.S."}], "meta": {"hits": 5, "offset": 0, "time": 44}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}